Delta Air Lines, Inc. vs Revvity Inc — how do they compare? Delta Air Lines, Inc. trades at $90.46 (market cap $58.67B), while Revvity Inc trades at $115.76 (market cap $12.94B). The key difference: Delta Air Lines, Inc. is far larger — about 4.5× Revvity Inc's market cap, and Delta Air Lines, Inc. pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| DAL | RVTY | |
|---|---|---|
Market Cap | $58.67B | $12.94B |
Sector | Industrials | Technology |
52-Week High | $93.66 | $117.75 |
52-Week Low | $55.65 | $82.26 |
Enterprise Value | $73.99B | $15.26B |
Dividend Yield | 0.87% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $114.66, up 0.37% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a 54.98% gross margin and $241.20M net income for 2025, supported by positive news including product launches and raised 2026 guidance. Analyst consensus is a buy with a $120.50 price target, indicating potential upside from current levels.
Outlook remains positive due to consistent earnings outperformance and innovation in diagnostics, but risks include high P/E valuation and competitive pressures. Investors may find opportunity in sustained margin strength and AI integration, though macroeconomic sensitivity warrants caution.
Trailing returns across standard periods
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →